Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...
Encouragingly, intratumoral delivery of recombinant calreticulin or systemic delivery of phosphatase 1 inhibitors in combination with conventional cytotoxic agents such as etoposide or mitomycin C ...